Verapamil Hydrochloride
Verapamil Hydrochloride Injection, USPIntravenous InjectionRx only
Approved
Approval ID
844a3351-51e8-4264-a01c-a5b6ce4f7093
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 30, 2023
Manufacturers
FDA
Methapharm Inc.
DUNS: 066672887
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
VERAPAMIL HYDROCHLORIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code67850-072
Application NumberANDA215829
Product Classification
M
Marketing Category
C73584
G
Generic Name
VERAPAMIL HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 18, 2023
FDA Product Classification
INGREDIENTS (4)
VERAPAMIL HYDROCHLORIDEActive
Quantity: 2.5 mg in 1 mL
Code: V3888OEY5R
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 8.5 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
VERAPAMIL HYDROCHLORIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code67850-071
Application NumberANDA215829
Product Classification
M
Marketing Category
C73584
G
Generic Name
VERAPAMIL HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 18, 2023
FDA Product Classification
INGREDIENTS (4)
VERAPAMIL HYDROCHLORIDEActive
Quantity: 2.5 mg in 1 mL
Code: V3888OEY5R
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 8.5 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT